Detalhe da pesquisa
1.
Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist.
Cancer Immunol Immunother
; 72(7): 2459-2471, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016127
2.
Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion.
Cancer Immunol Immunother
; 65(9): 1047-59, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27392940
3.
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2.
Cancer Immunol Immunother
; 65(12): 1523-1532, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27695964
4.
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma.
bioRxiv
; 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333207
5.
Ranking Antibody Binding Epitopes and Proteins Across Samples from Whole Proteome Tiled Linear Peptides.
bioRxiv
; 2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162956
6.
Single cell metabolic imaging of tumor and immune cells in vivo in melanoma bearing mice.
Front Oncol
; 13: 1110503, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020875
7.
Generation of Novel Immunocompetent Mouse Cell Lines to Model Experimental Metastasis of High-Risk Neuroblastoma.
Cancers (Basel)
; 15(19)2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835389
8.
Cyclophosphamide augments the efficacy of in situ vaccination in a mouse melanoma model.
Front Oncol
; 13: 1200436, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746303
9.
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639155
10.
NK cells propagate T cell immunity following in situ tumor vaccination.
Cell Rep
; 42(12): 113556, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096050
11.
Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen.
Front Immunol
; 14: 1221155, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38077403
12.
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822669
13.
Donor selection for ex vivo-expanded natural killer cells as adoptive cancer immunotherapy.
Future Oncol
; 13(12): 1043-1047, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28492088
14.
Roles of CD4+ T cells as mediators of antitumor immunity.
Front Immunol
; 13: 972021, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36159781
15.
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460335
16.
Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618290
17.
Short-course neoadjuvant in situ vaccination for murine melanoma.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039460
18.
Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model.
J Immunother Cancer
; 9(4)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858849
19.
Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172518
20.
Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models.
Front Immunol
; 12: 763888, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868010